Meta Platforms
META
Oracle
ORCL
Strategy
MSTR
4
Toll Brothers
TOL
5
MARA Holdings
MARA
US Stock MarketDetailed Quotes
OGN Organon & Co
- 9.590
- +0.140+1.48%
Close May 2 16:00 ET
- 9.540
- -0.050-0.52%
Post 18:56 ET
2.47BMarket Cap3.33P/E (TTM)
9.750High9.180Low13.58MVolume9.610Open9.450Pre Close127.81MTurnover5.29%Turnover Ratio2.88P/E (Static)257.95MShares22.28852wk High5.24P/B2.46BFloat Cap9.18052wk Low1.12Dividend TTM256.82MShs Float33.352Historical High11.68%Div YieldTTM6.03%Amplitude9.180Historical Low9.409Avg Price1Lot Size
About Organon & Co Company
Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.
Company Profile
SymbolOGN
Company NameOrganon & Co
Listing DateMay 14, 2021
Founded2020
CEOMr. Kevin Ali
MarketNYSE
Employees10000
Fiscal Year Ends12-31
Address30 Hudson Street,33rd floor
CityJersey City
ProvinceNew Jersey
CountryUnited States of America
Zip Code07302
Phone1-551-430-6900
Websitehttp://www.organon.com
Company Executives
- Name
- Position
- Salary
- Kevin Ali
- Chief Executive Officer and Director
- 17.12M
- Rachel A. Stahler
- Executive Vice President and Chief Digital & Growth Officer
- --
- Matthew M. Walsh
- Executive Vice President, Chief Financial Officer and Principal Accounting Officer
- 5.75M
- Aaron Falcione
- Executive Vice President and Chief Human Resources Officer
- --
- Dr. Juan Camilo Arjona Ferreira, M.D.
- Executive Vice President, Head of Research and Development and Chief Medical Officer
- 3.60M
- Kathryn DiMarco
- Senior Vice President and Corporate Controller
- --
- Vittorio Nisita
- Executive Vice President and Head of Enterprise Services & Solutions
- --
- Kirke Weaver
- Executive Vice President, General Counsel and Corporate Secretary
- --
- Joseph T. Morrissey, Jr
- Executive Vice President and Head of Manufacturing and Supply
- 4.13M
- Daniel Karp
- Executive Vice President, Corporate Development
- --
- Carrie S. Cox
- Chairman of the Board
- 450.00K
- Ramona A. Sequeira
- Director
- --
- Shalini Sharp
- Independent Director
- 345.00K
- Rochelle B. Lazarus
- Independent Director
- 320.00K
- Grace Puma Whiteford
- Independent Director
- 320.00K
- Deborah R. Leone
- Independent Director
- 330.00K
- Cynthia M. Patton
- Independent Director
- 330.00K
- Robert A. Essner
- Independent Director
- 335.00K
- Dr. Philip Ozuah, M.D.,PhD
- Independent Director
- 334.06K
- Dr. Helene D. Gayle, M.D.
- Independent Director
- 320.00K
- Dr. Alan Ezekowitz, M.D.,PhD
- Independent Director
- 330.00K
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call